Twitter Linkedin-in

Cell Series UK

: Speakers

Speakers

06 - 07 October 2020 | London, UK​
Book Now

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 Series.

Alan Smith

Alan Smith

Executive Vice President, Technical Operations
Bellicum Pharmaceuticals
Alex Bloom

Alex Bloom

Vice President Regulatory Affairs and Quality Assurance
Gyroscope Therapeutics
Francis Szele

Aline Hughson

Senior Process Scientist
Gyroscope Therapeutics
Andreas Unsoeld

Andreas Unsoeld

Head of Cell Culture Media
Boehringer Ingelheim Corporate Center GmbH
Angela Columbano

Angela Columbano

Head of Business Development & Partnering
Genethon
Annie Hubert

Annie Hubert

Senior Director, EU Section & Public Policy
Alliance for Regeneratice Medicine
Ashish Dugar

Ashish Dugar

Vice President, Global Medical Affairs
Sarepta Therapeutics
Asli Akidil

Asli Akidil

Senior Scientist, Oncology Safety Combinations
AstraZeneca
Benjamin Moritz

Benjamin Moritz

Principal Scientist - Process Sciences
Ichnos Sciences SA
Benoit Moreaux

Benoit Moreaux

Chief Scientific and Technological Officer
Bone Therapeutics
Bo Kara

Bo Kara

Vice President Process Development
Evox Therapeutics
Bobby Gaspar

Bobby Gaspar

President of Research & Cheif Scientific Officer
Orchard Therapeutics
Francis Szele

Britta Anderson

Senior R&D Scientist, Biopharmaceutical Expression Systems Team
Merck KGaA
Chaminda Salgado

Chaminda Salgado

Scientific leader, Cell & Gene Therapy Platform CMC
GlaxoSmithKline
Chris Bond

Chris Bond

Vice President, Cell ular Engineering
Kite, A Gilead Company
Chris Heery

Chris Heery

Chief Medical Officer
Precision BioSciences
Daniele Perna

Daniele Perna

Associate Fellow, Investigator Disruptive Technologies
GlaxoSmithKline
Francis Szele

David James

Professor of Bioprocess Engineering
University of Sheffield
David Kim

David Kim

Director, Global Supply Chain
Kite Pharma
Francis Szele

David Moss

Group Leader: Development Scientist (DSP)
Adaptimmune
Donna McLaren

Donna McLaren

Senior Director
Orchard Therapeutics
Dusko Ilic

Dusko Ilic

Professor of Stem Cell Science
King's College London
Erin Kimbrel

Erin Kimbrel

Executive Director of Regenerative Medicine
Astellas
Federico Mingozzi

Federico Mingozzi

Chief Scientific Officer
Spark Therapeutics
Francis Szele

Francis Szele

Associate Professor of Developmental Biology
University of Oxford
Frank Thielmann

Frank Thielmann

Operational Excellence Director - Region Europe
Takeda
Hans Keirstead

Hans Keirstead

Chief Executive Officer
Aivita Biomedical
Hans-Juergen Fuelle

Hans-Juergen Fuelle

Global Therapeutic Area Lead RA Pharmaceuticals GDD, NIBR DA Lead OPH & DAx for Early Development Regulatory Affaird
Novartis
Igor Rudychev

Igor Rudychev

Head of Data & Innovations, Global Commercial Innovation
AstraZeneca
Jak Knowles

Jak Knowles

Vice President, Venture Investments
Bayer
Janet Glassford

Janet Glassford

Senior Quality Assessor, Biological/Biotechnology Unit
MHRA
Francis Szele

Jenny Murray

Consultant to the ISIA Board of Directors
ISIA
Joachim Baer

Joachim Baer

Director, Cell Culture Development
Boehringer Ingelheim Corporate Center GmbH
Francis Szele

Jolanda Gerritsen

Assistant Director, Cell Line Development
Genmab
Jonathan Collins

Jonathan Collins

Senior Downstream Process and Technical Transfer Expert Manufacturing Science and Technology
Novartis
Francis Szele

Jonathon Orme

Global Head of Cell Banking
AstraZeneca
Keith Life

Keith Life

Senior Director of Gene Therapy manufacturing
Biomarin
Knut Niss

Knut Niss

Chief Technical Officer
Mustang Bio
Francis Szele

Kyle Grant

Associate Director of Vector Production
Voyager Therapeutics
Laure Twyffels

Laure Twyffels

Senior Scientist, R&D
Celyad
Francis Szele

Laurence Guianvarc’h

Head of Upstream Process Development
Novartis
Len Pattenden

Len Pattenden

Head of Biotherapeutics Development & Drug Supply
Cancer Research UK 
Lior Raviv

Lior Raviv

Vice President
Pluristem
Lisa Mohamet

Lisa Mohamet

Scientific Director & Fellow, Functional Genomics
GlaxoSmithKline
Lydia Teboul

Lydia Teboul

Head of Molecular & Cellular Biology
MRC Harwell
Manuel Carrondo

Manuel Carrondo

Vice President
Instituto de Biologia Experimental e Tecnologica
Mark Chen

Mark Chen

Manager, Cell Line Development, Cell and Gene Therapy Product Development
GlaxoSmithKline
Francis Szele

Mark Yang

Director
Genzyme
Matt Petroff

Matt Petroff

Senior Scientist
Spark Therapeutics
Michael Boychyn

Michael Boychyn

Vice President, Process Development
REGENXBIO
Min Wei

Min Wei

Director/Fellow
AstraZeneca
Mohamed Essameldin Abdelgawad

Mohamed Essameldin Abdelgawad

Associate Professor and Group Leader
Inserm
Mohammed Asmal

Mohammed Asmal

Vice Presdient and Head of Clinical Research & Development
bluebird bio
Mona Bausch

Mona Bausch

Scientist, Perfusion / Cell Culture Media
Merck KGaA
Mukesh Mayani

Mukesh Mayani

Principal Scientist - Gene Therapy
Sanofi
Nick Li

Nick Li

Senior Director, Health Economics & Outcomes Research
uniQure
Palani Palaniappan

Palani Palaniappan

Senior Vice President, Technical Operations
Sarepta Therapeutics
Pedro Campino

Pedro Campino

Director, Senior Global Regulatory Lead, Gene Therapies
CSL Behring
Petra Kaufmann

Petra Kaufmann

Vice President, R&D Translational Medicine
AveXis, A Novartis Company
Pilar Redondo

Pilar Redondo

Site Head, Cell Therapy Technology Center
Takeda
Qasim Rafiq

Qasim Rafiq

Associate Professor
UCL
Qi Cai

Qi Cai

Senior Scientist, Lead of Non-Viral Vector Delivery Project
Kite, A Gilead Company
Francis Szele

Rahul Pradhan

Group Leader
Kymab
Regina Fritsche Danielson

Regina Fritsche Danielson

Senior Vice President and Global Head of Research and Early Clinical Development, Cardiovascular, Renal and Metabolic Diseases
AstraZeneca
Rhiannon David

Rhiannon David

Associate Principal Scientist
AstraZeneca
Robert Deans

Robert Deans

Chief Innovation Officer
BlueRock Therapeutics
Rolf Koehler

Rolf Koehler

Group Head CLD1
Novartis
Ron Bates

Ron Bates

Director
Bristol-Myers Squibb
Sakis Mantalaris

Sakis Mantalaris

Professor of Biomedical Engineering
Georgia Institute of Technology
Saurabh Sen

Saurabh Sen

Principal Scientist
Boehringer Ingelheim Corporate Center GmbH
Francis Szele

Seshu Tyagarajan

CMC Team Leader
Novartis
Sharon Longhurst

Sharon Longhurst

Head of CMC
Immunicum
Simon Auslaender

Simon Auslaender

Group Leader Molecular & Cell Line Development
F. Hoffmann-La Roche Ltd
Simon Briggs

Simon Briggs

Senior Technical Product Steward for Kymriah
Novartis
Stefan Haider

Stefan Haider

Associate Director, Upstream Development
Boehringer Ingelheim Corporate Center GmbH
Francis Szele

Stefan Przyborski

Professor of Cell Technology
Durham University
Stefanos Grammatikos

Stefanos Grammatikos

Vice President, Head of Biotech Sciences
UCB PHARMA SA
Steve Okada

Steve Okada

Vice President and Head, Clinical Strategy, Regenerative Medicine
Takeda
Ta-Chun Hang

Ta-Chun Hang

Senior Scientist
bluebird bio
Tony D'Amore

Tony D’Amore

Vice President, Product Research & Development
Sanofi
Francis Szele

Ulrich Ruemenapp

Head of Launch Preparation and Coordination
Bayer AG
Francis Szele

Uwe Demelbauer

Global Head Drug Substance Development, Operational Sciences Mammalian
Novartis
Francis Szele

Vincent Dewar

Lead Monoclonal Antibodies Platform, Senior Manager
GlaxoSmithKline
Yun Tang

Yun Tang

Head of Cell Therapy Development Operations
Juno Therapeutics
Francis Szele

Yuval Shimoni

Principal Engineer
Bayer AG

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Cell Series 2019
Post-Event Report

Statistics, feedback, photos and more from last year's event

Read Now